SCHEMBL18015374

SCHEMBL18015374

Cc1ccc2c(n1)oc1c(-c3ccc(-c4ccccc4-c4cc(-c5ccccc5-c5ccc(-c6ccccc6)nc5)cc(-c5ccccc5-c5ccc(-c6ccccc6)nc5)c4)cn3)cccc12

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.36
ADORA2A P29274 4/20 0.36
DHODH Q02127 3/20 0.35
HPGDS O60760 1/20 0.34
ENPP3 O14638 2/20 0.34
ENPP1 P22413 1/20 0.34
TGFBR1 P36897 2/20 0.33
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
GSK3B P49841 1/20 0.33
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21125469 0.98 ENPP3 (0.35) ADORA1ADORA2ADHODHHPGDSENPP3
SCHEMBL21125944 0.97 HSD17B1 (0.36) ADORA1ADORA2AENPP3ENPP1TGFBR1
SCHEMBL18015598 0.93 ADORA1 (0.33) ADORA1ADORA2ADHODHENPP3ENPP1
SCHEMBL19794462 0.93 ENPP3 (0.34) ADORA1ADORA2ADHODHENPP3TGFBR1
SCHEMBL22059833 0.91 TGFBR1 (0.35) ENPP3ENPP1TGFBR1
SCHEMBL19933714 0.91 TGFBR1 (0.33) ADORA1DHODHENPP3ENPP1TGFBR1
SCHEMBL21397869 0.90 CDK1 (0.32) ADORA1ADORA2AHPGDSTGFBR1CDK1
SCHEMBL15673151 0.90 ADORA1 (0.34) ADORA1ADORA2ADHODHENPP3ENPP1
SCHEMBL21290220 0.90 PDCD1 (0.35) ADORA1ADORA2A
SCHEMBL21662052 0.88 CAMKK2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
WO-2016124304-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC ADORA1 933/4885ADORA2A 722/4885DHODH 3418/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 ADORA1 4700/4885ADORA2A 4686/4885DHODH 4176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.